Regulation - Asia-Pacific

Filter

Current filters:

Asia-Pacific

Popular Filters

101 to 125 of 247 results

Zydus' diabetes drug Lipaglyn becomes India's first NCE to reach the market

06-06-2013

Indian drugmaker Zydus Cadila today (June 5) made a breakthrough in its research efforts with Lipaglyn…

Asia-PacificDiabetesLipaglynPharmaceuticalRegulationZydus Cadila

Australia's TGA to consult on pharmacy-only drug advertising

03-06-2013

Australia's Therapeutic Goods Administration (TGA) has released a Regulation Impact Statement (RIS) on…

Asia-PacificMarkets & MarketingPharmaceuticalRegulation

Ahead of 2013 federal election, trade group makes plea for fixing Australia's PBS listing system

27-05-2013

Pharma trade group Medicines Australia today (May 27) launched its 2013 Federal Election document, calling…

Asia-PacificHealthcarePatentsPharmaceuticalPoliticsPricingRegulation

Astellas and Medivation file for approval of enzalutamide in Japan

24-05-2013

Japanese drug major Astellas Pharma (TYO: 4503) has submitted an application for marketing approval of…

Asia-PacificAstellas PharmaenzalutamideMedivationOncologyPharmaceuticalRegulationXtandi

Proposal to list Roche's Neulastim and Actemra in New Zealand

24-05-2013

New Zealand's Pharmaceutical Management Agency PHARMAC has announce the approval of a proposal to list…

ActemraAnti-Arthritics/RheumaticsAsia-PacificNeulastimOncologyPharmaceuticalPricingRegulationRoche

Number of new PBS medicines in Australia hits 20-year low

20-05-2013

The number of new medicines listed on the Australian Pharmaceutical Benefits Scheme (PBS) in 2011-12…

Asia-PacificHealthcarePharmaceuticalRegulation

Australia's revised code to benefit ASX-listed life science companies

16-05-2013

Australia's Minister for Technology, Gordon Rich-Phillips, this week joined forces with the Australian…

Asia-PacificBiotechnologyFinancialPharmaceuticalRegulation

US DoJ says Ranbaxy pleads guilty and agrees to pay $500 million in settlements

14-05-2013

In the largest drug safety settlement to date with a generic drug manufacturer, Ranbaxy USA, a subsidiary…

Asia-PacificDaiichi SankyoFinancialGenericsLegalNorth AmericaProductionRanbaxy LaboratoriesRegulation

GlaxoSmithKline and Theravance file for Japanese approval of Anoro Ellipta

22-04-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and US partner Theravance (Nasdaq: THRX) today April 22) announced…

Anoro ElliptaAsia-PacificGlaxoSmithKlinePharmaceuticalRegulationRespiratory and PulmonaryTheravance

New regulations to manage Vietnam pharmaceutical industry

12-04-2013

The Vietnam Ministry of Health has issued Circular No 10/2013/TT-BYT amending and supplementing a number…

Asia-PacificPharmaceuticalRegulation

New Zealand considers listing of Neulastim and Actemra

12-04-2013

New Zealand's Pharmaceutical Management Agency, PHARMAC, is seeking feedback on a proposal to list pegfilgrastim…

ActemraAnti-Arthritics/RheumaticsAsia-PacificBiotechnologyNeulastimOncologyPharmaceuticalPricingRegulationRoche

FDA approves Eisai's Aciphex Sprinkle for GERD in children; Inovelon OKed in Japan

28-03-2013

Japanese drug major Eisai (TYO: 4523) says that the US Food and Drug Administration has approved Aciphex…

AciphexAsia-PacificEisaiGastro-intestinalsInovelonNeurologicalNorth AmericaPharmaceuticalRegulation

Zeria and Astellas' Acofide approved in Japan for functional dyspepsia

27-03-2013

Japan's Ministry of Health, Labor and Welfare (MHLW) has approved the marketing of Acofide (acotiamide…

AcofideAsia-PacificAstellas PharmaGastro-intestinalsPharmaceuticalRegulationZeria Pharmaceuticals

Sinovac rockets on strong data for Enterovirus 71 vaccine

15-03-2013

Chinese vaccines maker Sinovac Biotech Ltd. (Nasdaq: SVA) saw its shares leap 53% to $4.88 in morning…

Asia-PacificEnterovirus 71PharmaceuticalRegulationResearchSinovacVaccines

Daiichi Sankyo updates on PRASFIT-Elective study, NDA filing

14-03-2013

Japanese drug major Daiichi Sankyo (TYO: 4568) says that the follow-up period for the Phase III PRASFIT-Elective…

Asia-PacificAspirinCardio-vascularDaiichi SankyoEffientPharmaceuticalprasugrelRegulationResearch

Consultation opens for Australian code of best practice for life science companies

14-03-2013

Trade group AusBiotech and the Australian Securities Exchange (ASX), with the support of the Victorian…

Asia-PacificBiotechnologyMarkets & MarketingPharmaceuticalRegulation

Astellas files for Japanese approval of ipragliflozin for types 2 diabetes

14-03-2013

Japanese drug major Astellas Pharma (TYO: 4503) has submitted a market authorization application for…

Asia-PacificAstellas PharmaDiabetesipragliflozinPharmaceuticalRegulation

101 to 125 of 247 results

Back to top